PriceTargets.com logo

RE/MAX - RMAX Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $10.38
  • Forecasted Upside: -21.16%
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$13.16 As of 12/3/2024 12:20 PM ET
▼ -0.14 (-1.05%)

This chart shows the closing price for RMAX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RE/MAX Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RMAX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RMAX

Analyst Price Target is $10.38
▼ -21.16% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for RE/MAX in the last 3 months. The average price target is $10.38, with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a -21.16% upside from the last price of $13.16.

This chart shows the closing price for RMAX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 5 polled investment analysts is to reduce stock in RE/MAX. This rating has held steady since December 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
3/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
6/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
9/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
11/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
12/3/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/12/2024StephensBoost TargetEqual Weight ➝ Equal Weight$9.00 ➝ $10.50
5/6/2024StephensLower TargetEqual Weight ➝ Equal Weight$10.00 ➝ $9.00
4/10/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$9.00 ➝ $7.00
3/1/2024JonestradingReiterated RatingBuy ➝ Hold
2/28/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$11.00 ➝ $10.00
12/18/2023JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$16.00 ➝ $14.00
11/7/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$19.50 ➝ $9.00
11/3/2023JonestradingLower TargetBuy ➝ Buy$22.00 ➝ $18.00
8/21/2023StephensReiterated RatingEqual Weight ➝ Equal Weight$21.00
8/4/2023JonestradingReiterated RatingBuy ➝ Buy$22.00
7/17/2023BTIG ResearchInitiated CoverageNeutral
2/21/2023StephensDowngradeOverweight ➝ Equal Weight$28.00 ➝ $21.00
11/7/2022StephensLower TargetOverweight$27.00 ➝ $26.00
9/26/2022JonestradingLower TargetBuy$34.00 ➝ $28.00
3/9/2022Morgan StanleyLower TargetEqual Weight$30.50 ➝ $28.50
3/2/2022JonestradingInitiated CoverageBuy$38.00
2/28/2022Keefe, Bruyette & WoodsLower Target$37.00 ➝ $35.00
12/9/2021Morgan StanleyLower TargetEqual Weight$33.50 ➝ $30.50
9/22/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$40.00 ➝ $33.50
7/21/2021Berenberg BankInitiated CoverageBuy$41.00
3/1/2021Compass PointDowngradeBuy ➝ Neutral$44.00
1/5/2021Morgan StanleyBoost TargetOverweight$37.00 ➝ $40.00
12/21/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$27.00 ➝ $36.00
8/10/2020StephensBoost TargetOverweight$39.00 ➝ $40.00
5/8/2020William BlairDowngradeOutperform ➝ Market Perform
5/8/2020Compass PointUpgradeNeutral ➝ Buy$32.00
3/13/2020StephensUpgradeEqual Weight ➝ Overweight$38.00
2/26/2020Morgan StanleyLower TargetOverweight$39.00 ➝ $37.00
(Data available from 12/3/2019 forward)

News Sentiment Rating

0.58 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 18 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
5/7/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/6/2024
  • 6 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/6/2024
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/5/2024
  • 2 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 8 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024
  • 6 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2024

Current Sentiment

  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

RE/MAX logo
RE/MAX Holdings, Inc. operates as a franchisor of real estate brokerage services in the United States, Canada, and internationally. It operates through Real Estate, Mortgage, and Marketing Funds segments. The company offers real estate brokerage franchising services under the RE/MAX brand; mortgage brokerage services to real estate brokers, real estate professionals, mortgage professionals, and other investors under the Motto Mortgage brand; and mortgage loan processing software and services under the wemlo brand. It also provides kvCORE platform, which integrates a suite of digital products that enables agents, brokers, and teams to establish and manage client relationships; and RE/MAX University platform, a learning hub designed to help each agent in their professional expertise. The company was founded in 1973 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $13.16
Low: $13.13
High: $13.44

50 Day Range

MA: $12.19
Low: $10.96
High: $14.04

52 Week Range

Now: $13.16
Low: $6.94
High: $14.31

Volume

27,587 shs

Average Volume

267,194 shs

Market Capitalization

$248.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of RE/MAX?

The following Wall Street research analysts have issued stock ratings on RE/MAX in the last year: Jonestrading, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Stephens, and StockNews.com.
View the latest analyst ratings for RMAX.

What is the current price target for RE/MAX?

0 Wall Street analysts have set twelve-month price targets for RE/MAX in the last year. Their average twelve-month price target is $10.38, suggesting a possible downside of 21.2%. JPMorgan Chase & Co. has the highest price target set, predicting RMAX will reach $14.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $7.00 for RE/MAX in the next year.
View the latest price targets for RMAX.

What is the current consensus analyst rating for RE/MAX?

RE/MAX currently has 2 sell ratings and 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for RMAX.

How do I contact RE/MAX's investor relations team?

RE/MAX's physical mailing address is 5075 SOUTH SYRACUSE STREET, DENVER CO, 80237. The financial services provider's listed phone number is (303) 770-5531 and its investor relations email address is [email protected]. The official website for RE/MAX is www.remax.com. Learn More about contacing RE/MAX investor relations.